Presentations in this session:

12:30 MoPp0101    Abstract Using live microbes as anti-HIV microbicides Hamer D.1, Henry K.1, Hu S.1, McHugh L.1, Lueders K.1, Adhya S.1, Rao S.2 1NCI, National Institutes of Health, Bethesda, United States of America, 2Vaccine Research Center, National Institutes of Health, Bethesda, United States of America

12:35 MoPp0102    Abstract The contraceptive microbicide whi-07 prevents genital transmission of feline immunodeficiency virus (FIV) in the vaginal and rectal transmucosal model for feline AIDS (FAIDS) D'Cruz O.J.1, Uckun F.M.2 1Parker Hughes Institute and Paradigm Pharmaceuticals, LLC, St. Paul, United States of America, 2Parker Hughes Institute, St. Paul, United States of America

12:40 MoPp0103    Abstract Synergistic and complementary effects of the anti-HIV-1 microbicides CAP and UC781 in combination Jiang S.1, Liu S.1, Lu H.1, Neurath A.R.1 1New York Blood Center, New York, United States of America

12:45 MoPp0104    Abstract Development of a human penile tissue explant model to evaluate safety and efficacy of microbicide candidates Shattock R.1, Fischetti L.1, Fletcher P.1, Hu Q.1, Harman S.1, Mesquita P.1 1St George's Hospital Medical School, London, United Kingdom

12:50 MoPp0105    Abstract TMC120 blocks HIV-1 infection in cellular and human cervical tissue models Harman S.1, Perumal D.1, Fletcher P.1, Van Roey J.2, Gwozdz G.3, Fairhurst D.3, Mitchnick M.3, Shattock R.1 1St Georges Hospital Medical School, London, United Kingdom, 2Tibotec BVBA, Mechelen, Belgium, 3International Partnership for Microbicides, Washington, United States of America

12:55 MoPp0106    Abstract Increased expression of human beta-defensin 2 in HIV-infected human colonic mucosa Lin J.1, Elliott J.1, Adler A.1, Anton P.1, McGowan I.1 1David Geffen School of Medicine at UCLA, Los Angeles, United States of America